NASDAQ:SWAV Shockwave Medical (SWAV) Stock Forecast, Price & News $276.14 -4.53 (-1.61%) (As of 05/30/2023 ET) Add Compare Share Share Today's Range$273.54▼$289.4750-Day Range$210.15▼$302.6852-Week Range$154.45▼$320.54Volume485,782 shsAverage Volume550,056 shsMarket Capitalization$10.11 billionP/E Ratio43.56Dividend YieldN/APrice Target$266.33 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Shockwave Medical MarketRank™ ForecastAnalyst RatingModerate Buy2.56 Rating ScoreUpside/Downside3.6% Downside$266.33 Price TargetShort InterestHealthy3.58% of Shares Sold ShortDividend StrengthN/ASustainability-0.55Upright™ Environmental ScoreNews Sentiment0.48Based on 16 Articles This WeekInsider TradingSelling Shares$6.01 M Sold Last QuarterProj. Earnings Growth25.44%From $3.97 to $4.98 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.41 out of 5 starsMedical Sector214th out of 1,009 stocksSurgical & Medical Instruments Industry22nd out of 104 stocks 1.3 Analyst's Opinion Consensus RatingShockwave Medical has received a consensus rating of Buy. The company's average rating score is 2.56, and is based on 6 buy ratings, 2 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $266.33, Shockwave Medical has a forecasted downside of 3.6% from its current price of $276.14.Amount of Analyst CoverageShockwave Medical has only been the subject of 3 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted3.58% of the outstanding shares of Shockwave Medical have been sold short.Short Interest Ratio / Days to CoverShockwave Medical has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Shockwave Medical has recently decreased by 7.75%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldShockwave Medical does not currently pay a dividend.Dividend GrowthShockwave Medical does not have a long track record of dividend growth. Previous Next 4.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreShockwave Medical has received a 72.86% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Diagnostic and treatment machines" and "Medical devices engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Shockwave Medical is -0.55. Previous Next 1.9 News and Social Media Coverage News SentimentShockwave Medical has a news sentiment score of 0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 16 news articles for Shockwave Medical this week, compared to 7 articles on an average week.Search InterestOnly 18 people have searched for SWAV on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Shockwave Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -70% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Shockwave Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $6,008,989.00 in company stock.Percentage Held by InsidersOnly 3.40% of the stock of Shockwave Medical is held by insiders.Percentage Held by Institutions90.56% of the stock of Shockwave Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Shockwave Medical are expected to grow by 25.44% in the coming year, from $3.97 to $4.98 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Shockwave Medical is 43.56, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 130.69.Price to Earnings Ratio vs. SectorThe P/E ratio of Shockwave Medical is 43.56, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 96.34.Price to Earnings Growth RatioShockwave Medical has a PEG Ratio of 25.90. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioShockwave Medical has a P/B Ratio of 19.52. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Shockwave Medical (NASDAQ:SWAV) StockShockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.Read More Receive SWAV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address SWAV Stock News HeadlinesMay 18, 2023 | marketbeat.comPharma Giants Novartis, Lilly, Merck, and Novo Outperform Market (SWAV)Big pharma stocks Novartis, Eli Lilly, Merck, and Novo Nordisk are outperforming the market, driven by successful drugs and strong earnings growth.May 15, 2023 | marketbeat.comShockwave Medical, Fast Grower, In Boston Scientific's Sights?Shockwave earnings are growing at triple-digit rates. The company easily beat Q1 views. Boston Scientific is reportedly interested in acquiring Shockwave.May 30, 2023 | Legacy Research (Affiliate) (Ad)Stocks are for suckers – try this insteadThis has nothing to do with dividends, day trading... taking out a loan... or anything like that. What you need is about 3 seconds to execute this simple financial maneuver...May 9, 2023 | marketbeat.comAre Small Caps a Harbinger of Market Declines? (SWAV)The iShares Russell 2000 ETF outperformed the S&P 500 last week, but that may be short-lived. Small-cap momentum is often a bellwether for broad-market action.May 26, 2023 | finance.yahoo.comThese Growth Stocks Seem Stalled. That May Be A Good Thing.May 26, 2023 | americanbankingnews.comQ3 2023 EPS Estimates for Shockwave Medical, Inc. Decreased by Analyst (NASDAQ:SWAV)May 24, 2023 | benzinga.comShockWave Medical Director Acquires 3,000 Shares After Exercising Company Stock OptionsMay 24, 2023 | finance.yahoo.comShockWave Medical (SWAV) Hits 52-Week High: Will it Continue?May 30, 2023 | Legacy Research (Affiliate) (Ad)Stocks are for suckers – try this insteadThis has nothing to do with dividends, day trading... taking out a loan... or anything like that. What you need is about 3 seconds to execute this simple financial maneuver...May 24, 2023 | msn.comShockwave Medical: Multiple Growth Levers To Drive Valuation UpsideMay 24, 2023 | americanbankingnews.comShockwave Medical, Inc. (NASDAQ:SWAV) Director Frank T. Watkins Sells 3,000 SharesMay 19, 2023 | finance.yahoo.comWith EPS Growth And More, Shockwave Medical (NASDAQ:SWAV) Makes An Interesting CaseMay 18, 2023 | benzinga.comShockWave Medical Stock (NASDAQ:SWAV), Insider Trading ActivityMay 18, 2023 | americanbankingnews.comShockwave Medical, Inc. (NASDAQ:SWAV) Given Consensus Recommendation of "Moderate Buy" by BrokeragesMay 17, 2023 | finance.yahoo.comShockwave Appoints Kevin Ballinger to Board of DirectorsMay 16, 2023 | finance.yahoo.comShockwave Medical (SWAV) Launches IVL Catheter in Select MarketsMay 15, 2023 | msn.comThis Favorable Sign Appears On ShockWave Medical's ChartMay 15, 2023 | finance.yahoo.comShockwave Medical Launches New Coronary IVL Catheter Internationally and Enrolls First Patient in All-Female Empower StudyMay 15, 2023 | americanbankingnews.comInsider Selling: Shockwave Medical, Inc. (NASDAQ:SWAV) CFO Sells $598,497.50 in StockMay 15, 2023 | americanbankingnews.comFinancial Contrast: Shockwave Medical (NASDAQ:SWAV) versus NeuroOne Medical Technologies (NASDAQ:NMTC)May 14, 2023 | americanbankingnews.comShockwave Medical, Inc. (NASDAQ:SWAV) Director Sara Toyloy Sells 235 SharesMay 12, 2023 | realmoney.thestreet.comShockwave Medical Could Shock With an Upside BreakoutMay 12, 2023 | americanbankingnews.comDeutsche Bank Aktiengesellschaft Raises Shockwave Medical (NASDAQ:SWAV) Price Target to $310.00May 12, 2023 | americanbankingnews.comNeedham & Company LLC Raises Shockwave Medical (NASDAQ:SWAV) Price Target to $325.00May 12, 2023 | americanbankingnews.comShockwave Medical (NASDAQ:SWAV) Receives Maintains Rating from VNET GroupMay 11, 2023 | finance.yahoo.comBallooning Sales, Profit Send Shockwave Into An Early BreakoutMay 11, 2023 | americanbankingnews.comPiper Sandler Boosts Shockwave Medical (NASDAQ:SWAV) Price Target to $315.00See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SWAV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address SWAV Company Calendar Last Earnings5/08/2023Today5/30/2023Next Earnings (Estimated)8/14/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SWAV CUSIPN/A CIK1642545 Webwww.shockwavemedical.com Phone(877) 775-4846FaxN/AEmployees1,001Year FoundedN/APrice Target and Rating Average Stock Price Forecast$266.33 High Stock Price Forecast$325.00 Low Stock Price Forecast$165.00 Forecasted Upside/Downside-4.2%Consensus RatingModerate Buy Rating Score (0-4)2.56 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)$6.34 Trailing P/E Ratio43.85 Forward P/E Ratio70.02 P/E Growth25.9Net Income$216 million Net Margins43.18% Pretax Margin26.36% Return on Equity55.22% Return on Assets41.44% Debt Debt-to-Equity Ratio0.04 Current Ratio4.16 Quick Ratio3.57 Sales & Book Value Annual Sales$489.73 million Price / Sales20.77 Cash Flow$6.07 per share Price / Cash Flow45.82 Book Value$14.15 per share Price / Book19.65Miscellaneous Outstanding Shares36,600,000Free Float35,356,000Market Cap$10.17 billion OptionableNot Optionable Beta0.99 Key ExecutivesDouglas Evan GodshallPresident, Chief Executive Officer & DirectorMike MaszySenior Vice President-OperationsDaniel PuckettChief Financial OfficerBeaux AlexanderVice President-Clinical AffairsW. Patrick StephensVice President-Research & DevelopmentKey CompetitorsTeleflexNYSE:TFXInspire Medical SystemsNYSE:INSPNovoCureNASDAQ:NVCRStevanato GroupNYSE:STVNPenumbraNYSE:PENView All CompetitorsInsiders & InstitutionsProShare Advisors LLCSold 934 shares on 5/26/2023Ownership: 0.018%Legato Capital Management LLCSold 569 shares on 5/25/2023Ownership: 0.005%Verity Asset Management Inc.Bought 328 shares on 5/24/2023Ownership: 0.013%Capital Impact Advisors LLCBought 151 shares on 5/23/2023Ownership: 0.013%Toroso Investments LLCBought 151 shares on 5/23/2023Ownership: 0.008%View All Insider TransactionsView All Institutional Transactions SWAV Stock - Frequently Asked Questions Should I buy or sell Shockwave Medical stock right now? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 1 sell rating, 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SWAV shares. View SWAV analyst ratings or view top-rated stocks. What is Shockwave Medical's stock price forecast for 2023? 9 analysts have issued 12 month price objectives for Shockwave Medical's stock. Their SWAV share price forecasts range from $165.00 to $325.00. On average, they predict the company's share price to reach $266.33 in the next twelve months. This suggests that the stock has a possible downside of 6.4%. View analysts price targets for SWAV or view top-rated stocks among Wall Street analysts. How have SWAV shares performed in 2023? Shockwave Medical's stock was trading at $205.61 at the start of the year. Since then, SWAV shares have increased by 38.4% and is now trading at $284.58. View the best growth stocks for 2023 here. When is Shockwave Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023. View our SWAV earnings forecast. How were Shockwave Medical's earnings last quarter? Shockwave Medical, Inc. (NASDAQ:SWAV) posted its quarterly earnings data on Monday, May, 8th. The company reported $1.03 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.81 by $0.22. The firm earned $161.10 million during the quarter, compared to analysts' expectations of $147.30 million. Shockwave Medical had a net margin of 43.18% and a trailing twelve-month return on equity of 55.22%. Shockwave Medical's revenue was up 72.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.39 EPS. What ETFs hold Shockwave Medical's stock? ETFs with the largest weight of Shockwave Medical (NASDAQ:SWAV) stock in their portfolio include Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), Northern Lights Fund Trust IV - Long Cramer Tracker ETF (LJIM), Neuberger Berman Disrupters ETF (NBDS), Invesco S&P MidCap 400 Pure Growth ETF (RFG), Invesco S&P MidCap Quality ETF (XMHQ), Pacer Lunt MidCap Multi-Factor Alternator ETF (PAMC), SPDR S&P Health Care Equipment ETF (XHE) and SoFi Next 500 ETF (SFYX). What guidance has Shockwave Medical issued on next quarter's earnings? Shockwave Medical issued an update on its FY 2023 earnings guidance on Monday, May, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $700.00 million-$720.00 million, compared to the consensus revenue estimate of $671.58 million. What is Doug Godshall's approval rating as Shockwave Medical's CEO? 8 employees have rated Shockwave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees. What other stocks do shareholders of Shockwave Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA). When did Shockwave Medical IPO? (SWAV) raised $75 million in an IPO on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers. What is Shockwave Medical's stock symbol? Shockwave Medical trades on the NASDAQ under the ticker symbol "SWAV." Who are Shockwave Medical's major shareholders? Shockwave Medical's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (12.38%), FMR LLC (7.16%), Price T Rowe Associates Inc. MD (3.82%), JPMorgan Chase & Co. (3.48%), State Street Corp (3.30%) and Artisan Partners Limited Partnership (2.90%). Insiders that own company stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, Laura Francis, Maria Sainz, Sara Toyloy, Sofinnova Capital Vii Fcpr and Trinh Phung. View institutional ownership trends. How do I buy shares of Shockwave Medical? Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Shockwave Medical's stock price today? One share of SWAV stock can currently be purchased for approximately $284.58. How much money does Shockwave Medical make? Shockwave Medical (NASDAQ:SWAV) has a market capitalization of $10.42 billion and generates $489.73 million in revenue each year. The company earns $216 million in net income (profit) each year or $6.34 on an earnings per share basis. How many employees does Shockwave Medical have? The company employs 1,001 workers across the globe. How can I contact Shockwave Medical? Shockwave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The official website for the company is www.shockwavemedical.com. The company can be reached via phone at (877) 775-4846 or via email at investors@shockwavemedical.com. This page (NASDAQ:SWAV) was last updated on 5/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shockwave Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.